Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Laser Vision Centers

This article was originally published in The Gray Sheet

Executive Summary

Registration for a secondary offering of 1.72 mil. shares, including 720,000 shares being sold by current shareholders, is filed with the SEC. The St. Louis-based laser vision correction services firm says the proceeds will be used to purchase additional equipment, fund possible future strategic acquisitions, make payments on previous acquisitions, expand patient financing programs, and for working capital and general corporate purposes. The growing popularity of laser vision correction helped spur a third-quarter (ended Jan. 31) revenue increase of 122% to $14.1 mil. Net income of $2.2 mil. compares to a loss of nearly $1 mil. for the comparable quarter one year ago. A.G. Edwards & Sons and Prudential Securities are underwriters for the offering

You may also be interested in...

Big Win For EMA On Transparency

The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.

UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector

Dr Reddy’s Focuses On India And China

Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts